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Abstract
 
Fas and the tumor necrosis factor receptor (TNFR)1 regulate the programmed cell death of
lymphocytes. The death domain kinase, receptor interacting protein (rip), is recruited to the
 
TNFR1 upon receptor activation. In vitro, 
 
rip
 
 
 
/
 
  
 
fibroblasts are sensitive to TNF-induced cell
 
death due to an impaired nuclear factor 
 
 
 
B response. Because 
 
rip
 
 
 
/
 
  
 
mice die at birth, we were
unable to examine the effects of a targeted 
 
rip
 
 mutation on lymphocyte survival. To address the
contribution of RIP to immune homeostasis, we examined lethally irradiated mice reconstituted
with 
 
rip
 
 
 
/
 
  
 
hematopoietic precursors. We observed a decrease in 
 
rip
 
 
 
/
 
  
 
thymocytes and T cells
in both wild-type C57BL/6 and recombination activating gene 1
 
 
 
/
 
  
 
irradiated hosts. In con-
trast, the B cell and myeloid lineages are unaffected by the absence of rip. Thus, the death do-
main kinase rip is required for T cell development. Unlike Fas-associated death domain, rip does
not regulate T cell proliferation, as 
 
rip
 
 
 
/
 
  
 
T cells respond to polyclonal activators. However, 
 
rip
 
-
deficient mice contain few viable CD4
 
  
 
and CD8
 
  
 
thymocytes, and 
 
rip
 
 
 
/
 
  
 
thymocytes are sen-
sitive to TNF-induced cell death. Surprisingly, the rip-associated thymocyte apoptosis was not
rescued by the absence of TNFR1, but appears to be rescued by an absence of TNFR2. Taken
together, this study implicates RIP and TNFR2 in thymocyte survival.
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B
 
Introduction
 
Antigen-induced T cell apoptosis is the result of the ex-
pression of death cytokines FasL/APO-1L and TNF (for
review see reference 1). The genes for FasL and TNF are
induced in IL-2–stimulated T cells (2). These death cyto-
kines engage the specific receptors Fas/APO-1 and the
TNFR1 (p55) and TNFR2 (p75). Defects in T cell apop-
tosis, lymphoproliferation, and autoimmunity result in cer-
tain strains of mice homozygous for the 
 
gld
 
 and 
 
lpr
 
 alleles,
which are genetic defects in FasL and Fas, respectively (3–
7). In humans, mutation of the Fas/APO-1/CD95 receptor
and other components of the death pathway also results in
the development of autoimmune lymphoproliferative syn-
drome (for review see reference 8).
The deregulation of TNF has also been associated with
autoimmune disease (9). TNF induces Fas-independent
apoptosis of mouse and human lymphoblasts and has been
implicated in thymocyte development (10–12). Further-
more, Fas-deficient T cells exhibit reduced but clearly evi-
dent TCR-induced cell death, and the residual apoptosis is
blocked by anti-TNF antibodies (11, 13). TCR-induced
 
apoptosis can also be inhibited in vivo using either anti-
 
TNF antibodies or in 
 
tnf
 
- and 
 
tnfr
 
1-deficient mice (10,
14–16).
TNF and FasL mediate their biological effects through
interaction with structurally related receptors. TNF binds
two distinct TNFRs: TNFR1 (p55) and TNFR2 (p75; for
review see reference 17). Most cell lines and tissues express
both receptors, although T cells express more TNFR2 (18,
 
11). The signaling pathway(s) for TNFR1 is now well
delineated. TNFR1, the major death-inducing receptor, re-
 
cruits TNFR1-associated death domain (TRADD)
 
*
 
, Fas-
associated death domain (FADD),
 
 
 
receptor interacting pro-
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RIP and TNFR2-induced Cell Death
 
tein (RIP), and TNFR-associated factor 2 (TRAF2) to the
receptor complex after TNF binding. A death signal is in-
duced by the recruitment of FADD and the subsequent
recruitment, cleavage/activation of caspase 8. Protection
from TNF-induced cell death in fibroblasts is mediated by
the activation of the transcription factor, nuclear factor
(NF)-
 
 
 
B (19–22). The death domain kinase rip plays a key
role in TNFR1 signaling as Jurkat cells and mouse embry-
onic fibroblasts deficient for rip are highly sensitive to
TNF-induced cell death due to a failure to activate the
transcription factor NF-
 
 
 
B (23, 24).
TNFR2 lacks a cytoplasmic death domain and is thought
to mediate proliferative signals to thymocytes (25, 26).
TNFR2 also contributes to TNF-induced cell death (27),
although the mechanism(s) by which R2 contributes to
TNF-induced cell death is controversial. Some studies sug-
gest that TNFR2-mediated death is mediated by TNFR1
(27, 28). However, studies in T cells suggest that TNFR2
contributes to cell death independently of TNFR1 (2, 29).
TNFR2 activates the transcription factor NF-
 
 
 
B pre-
sumably by recruiting TRAF1 and TRAF2 proteins to the
receptor (30, 31). The regulation of TNFR2-induced cell
death may involve the inhibitors of apoptosis (c-IAP–1 and
c-IAP-2), which have also been found associated with the
cytoplasmic domain of TNFR2 (32).
To determine whether the TRADD kinase rip partici-
pates in immune development and survival, we investi-
gated the effect(s) of rip deletion in lymphocytes. Because
targeted mutation of rip results in lethality, we examined
the effects of 
 
rip
 
 mutation by reconstituting mice with 
 
rip
 
 
 
/
 
 
 
fetal liver precursors.
 
Materials and Methods
 
Adoptive Transfer of Fetal Liver Cells.
 
Timed matings were
prepared from 
 
rip
 
 heterozygous mice. Fetal livers were harvested
from embryonic day 14 embryos and single cell suspensions were
prepared. DNA was prepared from the limbs and tails of embryos
for genotyping. Approximately 2 
 
  
 
10
 
6 
 
fetal liver cells were in-
jected into the tail vein of lethally irradiated recipient mice. Be-
fore injection, C57BL/6 recipients were exposed to a total of
1,200 rads of 
 
 
 
-irradiation in a split dose fashion. In other experi-
ments, fetal liver cells were transplanted into recombination acti-
vating gene 1
 
 
 
/
 
  
 
(C57BL/6) recipient mice that had been ex-
posed to 500 rads of 
 
 
 
-irradiation.
 
Generation of rip
 
 
 
/
 
 
 
/tnf
 
 
 
/
 
 
 
, rip
 
 
 
/
 
 
 
/tnfr1
 
 
 
/
 
 
 
, and rip
 
 
 
/
 
 
 
/tnfr2
 
 
 
/
 
 
 
Mice.
 
Double-mutant mice were generated by intercrossing
 
rip
 
 
 
/
 
  
 
and 
 
tnf
 
 
 
/
 
 
 
,
 
 
 
and 
 
tnfr1
 
 
 
/
 
  
 
and 
 
tnfr2
 
 
 
/
 
 
 
 
 
mice (provided by M.
Marino, Memorial Sloan-Kettering Cancer Center, New York,
NY). Tail biopsies were performed on 3-wk-old weanlings and
DNA was isolated for genotyping. 
 
Rip
 
 genotyping was performed
as previously described (23). 
 
Tnf
 
,
 
 tnfr1
 
, and 
 
tnfr2
 
 genotyping was
performed as previously described (33). Mice were weighed daily
to identify double-mutant animals. Double-mutant mice were
analyzed between 2 and 14 d after birth.
 
Flow Cytometry.
 
Thymus, spleen, and lymph nodes were re-
moved from transplanted mice at various time points after recon-
stitution. Donor cells were detected by staining cell suspensions
with FITC- or biotinylated-Ly9.1 followed by avidin-APC and
PE-conjugated anti-CD3, -CD4, -CD8, -B220, –Mac-1, and
 
–Gr-1 (BD PharMingen). Cells were stained with monoclonal an-
tibodies for 30 min at 4°C in PBS containing 1% BSA and 0.1%
sodium azide. Cells were analyzed on a FACScan™ (Becton
Dickinson). To characterize the double negative (DN) thymocyte
population, the thymus was stained with a cocktail of antibodies
including biotinylated-IgM, –Ter 119, -Gr1, –Mac-1, -PanNK,
-CD3, -CD4, and -CD8. Some samples were then stained
with FITC-CD44, PE-CD25, and Streptavidin-CyChrome (BD
PharMingen).
To quantitate apoptosis, thymocytes from wild-type, 
 
rip
 
 
 
/
 
 
 
,
 
rip
 
 
 
/
 
 
 
/tnfr1
 
 
 
/
 
 
 
, and 
 
rip
 
 
 
/
 
 
 
/tnfr2
 
 
 
/
 
 
 
 
 
mice were stained directly
with FITC–annexin V and propidium iodide or with 7-amino-
actinomycin D and analyzed by flow cytometry.
For TNF-induced apoptosis, wild-type or 
 
rip
 
 
 
/
 
  
 
thymocytes
were left untreated or treated with 50 ng/ml mTNF and 50 
 
 
 
g/
ml cycloheximide for 18 h, stained with FITC–annexin V and
propidium iodide (BD PharMingen), and analyzed by flow cy-
tometry.
 
Fetal Thymic Organ Culture.
 
Thymic lobes were removed
from fetuses on day 16, placed on a strip of nitrocellulose sup-
ported by a sterile metal grid, and incubated in RPMI supple-
mented with 10% fetal calf serum and 5 
 
  
 
10
 
 
 
5 
 
M 
 
 
 
-mercapto-
ethanol, 1 mM glutamine, and 1% penicillin/streptomycin. At the
indicated times, the thymic lobes were resuspended and stained
with FITC-CD4 and PE-CD8 and analyzed on a FACScan™ in-
strument. To genotype fetuses, DNA was isolated from tail and
limb biopsies.
 
Proliferation and NF-
 
 
 
B Assays.
 
Splenocytes from mice re-
constituted with wild-type or 
 
rip
 
 
 
/
 
  
 
fetal liver precursors were
stained with 2.5 
 
 
 
M carboxyfluorescein diacetate succinimidyl
ester (CFSE) and then left untreated or stimulated with 2 
 
 
 
g/ml
Con A or 10 
 
 
 
g/ml plate-bound anti-CD3 (145-2C11; BD
PharMingen) for 96 h. Cultures were then stained with antibod-
ies to APC-Ly9.1, PE-CD4, or PE-CD8 and proliferation was
assessed by CFSE fluorescence.
Splenocytes from 
 
rip
 
 
 
/
 
 
 
/tnfr1
 
 
 
/
 
 
 
 
 
and 
 
rip
 
 
 
/
 
 
 
/tnfr1
 
 
 
/
 
 
 
 
 
neonatal
mice were cultured in RPMI 1640 supplemented with 10% fetal
calf serum, 100 U/ml penicillin/streptomycin, and 2 mM gluta-
mine in 96-well plates (10
 
5 
 
cells/well). Splenocytes were stimu-
lated with 2 
 
 
 
g/ml Con A and 10 
 
 
 
g/ml anti-CD3 (145-2C11;
BD PharMingen) for 48 h. The cultures were pulsed with 50 
 
 
 
Ci
[
 
3
 
H]thymidine (NEN Life Science Products) for 18 h and har-
vested using a semiautomatic sample harvester. Incorporation of
radioactivity was measured by scintillation counting.
To assay nuclear NF-
 
 
 
B, thymocytes were harvested from
 
rip
 
 
 
/
 
 
 
/tnfr1
 
 
 
/
 
 
 
, 
 
rip
 
 
 
/
 
 
 
/tnfr1
 
 
 
/
 
 
 
, or 
 
rip / /tnfr1 /  neonatal mice
at day 6 and incubated in media alone or in media containing 50
ng/ml mTNF for 1 h. Nuclear extracts were prepared and p65
was detected by immunoblotting with anti-p65 antisera (Santa
Cruz Biotechnology Associates, Inc.). To confirm equivalent
amounts of nuclear protein, immunoblots were reprobed with
antibody to the nuclear corepressor protein msin3A.
Results
T Cell Development Is Affected in Mice Reconstituted with
rip /  Precursors. To investigate the contribution of rip to
lymphocyte development, lethally irradiated C57BL/6
mice were reconstituted with embryonic day 14 129/Sv
wild-type and rip /  fetal liver precursor cells. An antibody
for the allelic Ly9.1 antigen distinguished donor (129/Sv
mice are Ly9.1 ) from host cells (B6 mice are Ly9.1 ). 617 Cusson et al.
wk after reconstitution, three recipient mice were killed
and the thymus, spleen, and lymph node were analyzed for
the presence of Ly9.1  cells. 10-fold decreases in the num-
ber of cells in the lymph nodes and thymus isolated from
rip /  reconstituted mice were observed. In contrast, simi-
lar numbers of splenocytes were observed in wild-type and
rip /  reconstituted mice.
In addition to fewer cells in the rip /  reconstituted thy-
mus, the percentage of wild-type versus rip / -derived
cells was also different. In rip /  reconstituted mice, 97% of
the thymus contained Ly9.1  cells, whereas only 3% of
thymocytes in the rip /  reconstituted mice were donor
derived (Fig. 1 A). Although few rip /  thymocytes were
detected in the reconstituted mice, the CD4/CD8 profile
did not reveal any developmental changes in rip /  thy-
mocytes.
Interestingly, rip /  T cells were detected in the periph-
ery. The peripheral lymphoid organs of three wild-type or
three rip /  reconstituted mice were analyzed 12 wk after
reconstitution. One representative experiment is shown in
Fig. 1. In the cervical lymph nodes of rip /  reconstituted
mice, 17% of the CD3  cells also stained positive for Ly9.1
and were derived from rip /  cells (Fig. 1 B). In contrast,
mice reconstituted with rip /  precursors contained 67%
CD3  Ly9.1  cells in the cervical lymph nodes (Fig. 1 B).
Wild-type reconstituted mice contained 53% Ly9.1 
CD4  cells and 16% CD8  T cells in the cervical lymph
nodes. In contrast, 2.5% of Ly9.1  CD4  cells and 4% of
the Ly9.1  CD8  cells were detected in the cervical lymph
nodes of mice reconstituted with rip /  precursors. Few
peripheral rip /  T cells were also observed in the spleen
(Fig. 1 C) and the inguinal and mesenteric lymph nodes
(unpublished data).
Previous studies have implicated Fas in CD4 T cell sur-
vival and TNF in CD8 T cell survival (11). Because rip
mediates TNFR1 signaling, we expected the CD8 lineage
to be affected by an absence of rip. However, both the
CD4 and CD8 T cell lineages were affected by an absence
of rip.
In contrast to the T cell lineage, rip /  precursors con-
tributed to the B lymphoid and myeloid cell lineages. Sim-
ilar numbers of FITC-Ly9.1 and PE-B220  cells were ob-
served in the spleens of three rip /  (36, 38, and 35%) and
three rip /  (29, 35, and 36%) reconstituted mice (Fig. 1
C). Equal numbers of FITC-Ly9.1 and PE–Mac-1  cells
were also observed (unpublished data). Thus, the death do-
main kinase rip does not appear important in B cell or my-
eloid lineage development but is required for the normal
development of the T lineage.
An Age-dependent Decrease in rip /  Thymocytes. The de-
crease in rip /  thymocytes and mature T cells in the re-
constituted mice suggests that the lack of rip /  T cells may
reflect a deficiency in committed thymocyte precursors. To
determine whether equal numbers of rip /  and rip /  thy-
mocytes could be detected at early time points, wild-type
and rip /  reconstituted recombination activating gene 1 / 
mice were killed 2 wk after reconstitution and thymi
were stained with FITC-Ly9.1 and PE-CD3, and PE-CD4
and PE-CD8. Similar numbers of Ly9.1  donor-derived
thymocytes were observed in mice reconstituted with
wild-type (14%) or rip /  (12%) precursors (Fig. 2 A). Ad-
ditional reconstituted mice were then killed 6 wk after re-
constitution. Although sufficient numbers of Ly9.1  thy-
mocytes were observed in three rip /  reconstituted mice
(86, 83, and 87%), only 13% (11, 14, and 13%) of thy-
mocytes were derived from rip /  precursors (Fig. 2 B).
These studies suggest that in the absence of rip, thymocytes
either fail to proliferate or undergo cell death.
Rip /  T Cells Respond to Mitogens. The age-dependent
decrease in rip /  thymocytes and the lack of mature rip / 
T cells in the reconstituted mice may reflect the fact that
rip, like fadd, mediates proliferative pathways in lympho-
cytes (34). To examine this possibility, splenocytes from
mice reconstituted with wild-type and rip /  precursors
were labeled with CFSE and then stimulated in vitro with
anti-CD3 antibody or Con A. 4 d later, the cultures were
stained with antibodies to Ly9.1, CD4, and CD8. To de-
termine whether rip /  T cells proliferate in response to
mitogenic stimulation, we gated on the CFSE  Ly9.1 
cells. Cells from mice reconstituted with wild-type or rip / 
cells proliferated in response to Con A or anti-CD3, as
evidenced by the decrease in CFSE fluorescence relative
to the unstimulated cells (Fig. 3 A). However, rip /  T
cells consistently exhibit a twofold decrease in the prolifer-
ative response when compared with wild-type T cells.
This decreased response may reflect the limited numbers
of rip /  T cells in the splenocyte cultures (Fig. 3 B). In
the experiment shown in Fig. 3 A, the rip /  reconstituted
spleen contains 2.8% Ly9.1  CD4  cells and 1% Ly9.1 
CD8  cells, whereas wild-type reconstituted spleen con-
tains 18% Ly9.1  CD4  cells and 5.8% Ly9.1  CD8  cells
(Fig. 3 B).
Although decreases in the rip /  T cell proliferative re-
sponses were observed, we do not think this difference suf-
ficiently explains the absence of rip /  thymocytes and ma-
ture T cells in the reconstituted mice. Rip /  T cells, like
rip /  murine embryonic fibroblasts, may fail to survive be-
cause they are sensitive to TNF-induced cell death (24). To
test this hypothesis genetically, we examined thymocyte
development in neonatal rip / ,  rip / /tnf / ,  rip / /
tnfr1 / , and rip / /tnfr2 /  mice.
An Absence of TNF or TNFR1, but Not TNFR2, Partially
Rescues the RIP-associated Lethality. To determine whether
the rip-associated T cell defect(s) were TNF-mediated, we
generated rip / /tnf / , rip / /tnfr1 / , and rip / /tnfr2 / 
mice. The absence of TNF and TNFR1 improved the
survival of rip /  mice, with rip / /tnf /  mice surviving
an average of 5–6 d. Mice deficient for both rip and tnfr1
survived for the longest period, with double-mutant ani-
mals surviving an average of 12 d (Table I). The absence of
the TNFR2 failed to rescue the rip-associated lethality, as
both rip /  and rip / /tnfr2 /  mice died during the peri-
natal period. These data are consistent with the rip-associ-
ated lethality being TNFR1-mediated.
The rip / /tnfr1 /  mice appear normal at birth and are
indistinguishable from littermates. However, by day 2,18 RIP and TNFR2-induced Cell Death
Figure 1. Flow cytometric analysis of mice reconstituted with rip /  or rip /  fetal liver precursors. (A) Flow cytometric analysis of thymus. Single cell
suspensions of thymocytes were stained for the donor-specific Ly9.1 marker and for CD4 or CD8 12 wk after reconstitution. (B) Flow cytometric anal-
ysis of peripheral lymphocytes. Single cell suspensions of cervical, inguinal, and mesenteric lymph nodes from rip /  and rip /  reconstituted mice were
stained with FITC-Ly9.1 and PE–anti-CD3, PE-CD4, or PE-CD8. (C) Splenocytes were also stained with FITC-Ly9.1 and CD3-PE, CD4-PE, CD8-PE,
PE-B220, or PE–Mac-1. 10,000 events were collected. Plots are representative of three independent experiments.19 Cusson et al.
Figure 2. Flow cytometric analysis of thymocytes from mice reconstituted with rip /  and rip /  precursors 2 and 6 wk after reconstitution. (A) Thy-
mocytes from three wild-type and three rip /  reconstituted mice 2 and (B) 6 wk after reconstitution were analyzed with FITC–anti-Ly9.1 and PE–anti-
CD3, PE–anti-CD4, or PE–anti-CD8.20 RIP and TNFR2-induced Cell Death
Figure 3. Rip /  T cells respond to polyclonal activators. (A) Splenocytes from mice reconstituted with rip /  and rip /  precursors were labeled with
2.5  M CFSE and left untreated or stimulated with Con A or plate-bound anti-CD3 for 96 h. The proliferation of rip /  T cells was determined by
staining with APC-Ly9.1 and PE-CD3, PE-CD4, or PE-CD8. The results were reproduced in three independent experiments. (B) Few rip /  T cells in
the reconstituted spleen. Splenocytes from mice reconstituted with rip /  or rip /  fetal liver precursors were stained with APC-Ly9.1 and PE-CD4 or
PE-CD8. Three wild-type and three rip /  reconstituted mice were analyzed. The data shown is representative of three independent experiments.21 Cusson et al.
double-mutant animals are evident because they appear
runt-like and cachectic. By day 7, rip / /tnfr1 /  mice
only weigh one third of control rip / /tnfr1 /  and rip / /
tnfr1 /   littermates (unpublished data). Histopathologic
examination of the rip /  and rip / /tnfr1 /  mice failed
to reveal the reason for the death of mutant animals. Stud-
ies on relA / /tnf / ,  relA / /tnfr1 / , and Ikk-  / /
tnfr1 /  mice have suggested that the mice are immuno-
compromised due to a failure to activate NF- B and as a
result die from opportunistic infections (35–37). Thus far,
gram and silver staining of paraffin-embedded sections of
rip / /tnfr1 /  animals has failed to detect any evidence of
infection.
Mitogenic Responsiveness in the Absence of RIP and
TNFR1. Rip-deficient T cells can be detected in the pe-
ripheral lymphoid organs of mice reconstituted with rip / 
precursors and in rip / /tnfr1 /  neonatal mice. To further
examine the contribution of rip to T cell proliferation, we
compared the mitogenic response of rip / /tnfr1 /  and
rip / /tnfr1 /  splenic T cells. Consistent with our findings
on the reconstituted mice, rip / /tnfr1 /  T cells as well as
control littermates proliferated when stimulated with Con
A or anti-CD3 treatment (Fig. 4). These studies confirm
our proliferative studies of rip /  T cells in the reconsti-
tuted mice and fail to reveal a regulatory role for the death
domain kinase rip in T cell proliferation.
Double Positive (DP) Thymocyte Apoptosis in the Absence of
RIP. To determine whether targeted mutation of rip af-
fects thymocyte survival, we isolated fetal thymus from a rip
heterozygous mating and stained the thymocytes with anti-
CD4 and -CD8 antibodies and analyzed them by flow cy-
tometry. A decrease in rip /  DP thymocytes was observed
(Fig. 5 A). In contrast to thymus from control littermates,
which on average contained 83% CD4 and CD8 DP cells,
the  rip /  thymus only contained 18% viable DP thy-
mocytes. Moreover, an average fivefold increase in the DN
thymocyte population was also observed.
Analysis of the fetal thymus from day 18 rip /  embryos
revealed variation in the penetrance of the DP thymocyte
phenotype. For example, in four rip heterozygous matings
analyzed at embryonic day 18, 2/3, 1/4, 2/2, and 1/3 of
the rip /  mutants were affected (i.e., exhibited  50% loss
of DP thymocytes; unpublished data). Where rip /  DP
thymocyte loss is observed, we consistently observe an av-
erage of eightfold increase in the percent of apoptotic cells,
detected by FITC–annexin V/propidium iodide or 7-AAD
staining (unpublished data). Therefore, rip /  embryos with
normal CD4/CD8 profiles are observed, suggesting that
thymocyte development/expansion occurs normally in the
absence of rip, but that rip appears required for CD4 CD8
DP thymocyte survival.
To test whether the DP thymocyte loss may reflect sen-
sitivity of rip /  thymocytes to TNF-induced cell death,
thymocytes were incubated with mTNF in the presence
of cycloheximide for 18 h and the apoptotic cells were
detected by FITC–annexin V/PI staining. Wild-type thy-
mocytes treated with TNF were resistant to TNF-induced
cell death with 4.5% of thymocyte staining with FITC–
annexin V/PI (Fig. 5 B). A 7–10-fold increase in apop-
totic thymocytes was observed when rip /  thymocytes
were treated with mTNF. Therefore, rip /  thymocytes,
like the rip /  murine embryonic fibroblasts, appear sen-
sitive to TNF-induced cell death. Consistent with the
TNF sensitivity observed in vitro, DP thymocyte loss was
not observed in neonatal rip / /tnf /  mice (unpublished
data).
Table I. Genetic Analysis of Offspring Obtained from rip / , rip / /tnf / , rip / /tnfr1 / , and rip / /tnfr2 /  Heterozygous Matings
rip genotypes  /   /   /  Total
Male rip /    Female rip /  54 67  1  121
Male rip / /tnf /    Female rip / /tnf /  tnf genotypes  /  64 94 41  199
Male rip / /tnfr1 /    Female rip / /tnfr1 /  tnfr1 genotypes  /  49 118 106  273
Male rip / /tnfr2 /    Female rip / /tnfr2 /  tnfr2 genotypes  /  23 43  1 6 9
Breeding cages were examined daily and the number of pups born to each female was recorded. Tail biopsies were taken between days 2 and 6, and
genotyping was performed as described in Materials and Methods.
Figure 4. T cell proliferation in the absence of rip and tnfr1. Spleno-
cytes from rip / /tnfr1 / , rip / /tnfr1 / , and rip / /tnfr1 /  neonatal
mice were left untreated or stimulated with Con A and anti-CD3. Incor-
poration of [3H]thymidine was determined by standard procedures. Data
shown is representative of three independent experiments.22 RIP and TNFR2-induced Cell Death
The RIP-associated Thymocyte Apoptosis Is Not Mediated
through TNFR1. To determine whether the rip-associ-
ated thymocyte apoptosis was TNFR1-mediated, we ex-
amined the CD4/CD8 profiles of the rip / /tnfr1 /  and
rip / /tnfr1 /  neonatal thymus. Dramatic differences in
the overall cellularity were observed, suggesting that sur-
vival is not mediated through the TNFR1. The rip-defi-
cient thymus consists of 10  fewer thymocytes than rip / /
tnfr1 /  littermates (Fig. 6 B). Similar to what was ob-
served in the rip /  thymus, four- to sevenfold increases in
the percent of apoptotic cells were also observed in the
rip / /tnfr1 /  thymocytes by staining with FITC–annexin
Figure 5. Rip-deficient DP
thymocytes are sensitive to
TNF-induced cell death. (A)
Thymocytes from rip /   and
rip /  neonatal mice were
stained with PE–anti-CD4,
FITC–anti-CD8, and the fluo-
rescent DNA binding dye, LDS-
751. Viable cells were analyzed
for the expression of CD4 and
CD8 by flow cytometry. (B)
Thymocytes from rip / , rip / ,
and rip /  neonates were left un-
treated or treated with mTNF
and cycloheximide for 18 h.
Apoptotic cells were quantitated
by FITC–annexin V/PI staining.
Three  rip heterozygous litters
were examined. One representa-
tive experiment is shown. The
percent of apoptotic cells is shown
in the upper right quadrant.
Figure 6. DP thymocyte
apoptosis in the absence of rip
and  tnfr1. Flow cytometric
analysis of thymocytes from
rip / /tnfr1 /   and  rip / /
tnfr1 /  mice. (A) Thymocytes
from day-6 rip / /tnfr1 /  and
rip / /tnfr1 /   mice were
stained with PE–anti-CD4,
FITC–anti-CD8, and LDS-
751. The percent of viable cells
are indicated in each quadrant.
(B) Thymocyte and spleen cell
counts of rip / /tnfr1 /  and
rip / /tnfr1 /  mice. Cell
counts were performed in trip-
licate. Results are expressed  
SEM of at least six animals be-
tween 6 to 8 d old. (C) Thymus
from control littermates and
rip / /tnfr1 /  mice was stained
with a lineage-specific cocktail
containing biotinylated-IgM, -Ter
119, -Gr1, –Mac-1, -PanNK,
-CD3, -CD4, and -CD8. Some
samples were then stained with
FITC-CD44, PE-CD25, and
Streptavidin-CyChrome. The
Cy  or DN cells were further
analyzed according to their ex-
pression of CD44 and CD25. The percent of positive cells are indicated in each quadrant. Seven rip / /tnfr1 /  mice and seven littermate controls
were analyzed. One representative experiment is shown.23 Cusson et al.
V/PI or 7-AAD (unpublished data). In addition to the de-
creased cellularity and increase in apoptotic cells, there
were concomitant decreases in the DP thymocyte popula-
tion (31, 66, 29, and 56% in four age-matched rip / /
tnfr1 /  mice compared with 84, 83, 86, and 88% in litter-
mate controls). Thus, the absence of RIP resulted in an av-
erage 22-fold decrease in the absolute numbers of DP thy-
mocytes.
There were concomitant increases in the relative per-
centage of CD4  CD8  DN thymocytes (35, 23, 12, and
17% in rip / /tnfr1 /  mice compared with 7, 4, 3, and 8%
in control littermates; Fig. 6 A). Additional analysis of the
DN thymocytes isolated from the rip / /tnfr1 /  mice re-
vealed an increase in the CD44  CD25  DN precursor
thymocytes, suggesting that an absence of rip induces a par-
tial thymocyte arrest at the DN3 stage.
Thymocyte Survival in rip / /tnfr2 /  Mice. In the ab-
sence of TNFR1, rip /  DP thymocytes undergo apoptosis
and fail to survive, which suggests that rip /  and rip / /
tnfr1 /  thymocytes may undergo TNFR2-induced cell
death. The TNFR2 (p75) has also been implicated in im-
mune homeostasis (for review see reference 8). To test
whether the thymocyte apoptosis observed in the rip / /
tnfr1 /  mice is TNFR2-mediated, we examined the neo-
natal rip / /tnfr2 /  and rip / /tnfr2 /  thymus. In con-
trast to the decreased cellularity observed in the rip /  and
rip / /tnfr1 /  thymus, the neonatal rip / /tnfr2 /  thy-
mus contained similar numbers of total thymocytes as con-
trol littermates (Fig. 7 A). Surprisingly, in the absence of rip
and TNFR2, no decreases in the relative percentage of DP
thymocytes were observed (Fig. 7 B). Similar numbers of
DP thymocytes were detected in rip / /tnfr2 /  mice (72,
84, 82, 95, and 92%) as seen in littermate controls (86, 83,
85, 93, 92, and 90%). Consistent with these studies, no sig-
nificant increase in the percent of apoptotic cells was ob-
served (unpublished data). These studies implicate TNFR2
in DP thymocyte survival and suggest that rip participates
in TNFR2 signaling.
Thymocyte Apoptosis in the Presence of Nuclear p65. The
nature of the rip-mediated survival signal in rip / /tnfr1 / 
thymocytes does not appear to involve the activation of
p65 subunit of NF- B. We observed nuclear NF- B (p65)
in untreated rip / /tnfr1 /  and rip / /tnfr1 /  thymo-
cytes (Fig. 8 A, lanes 2 and 3, respectively) and rip / /
tnfr1 /  thymocytes (Fig. 8 A, lane 1). Furthermore, an in-
crease in nuclear p65 was not observed when either wild-
type or rip / /tnfr1 /   thymocytes were treated with
mTNF, suggesting that TNFR2 activates other survival
pathways (Fig. 8 A, lane 4, rip / /tnfr1 / , 5 rip / /tnfr1 / ,
and 6 rip / /tnfr1 / ). As expected, nuclear translocation
of p65 was observed when murine embryonic fibroblasts
were treated with mTNF (Fig. 8 A, lane 8). To control for
equivalent amounts of nuclear protein, the immunoblots
were probed with an antibody to the nuclear corepressor
protein, msin3A.
Discussion
Previous work has revealed that the death domain kinase
rip is an important mediator in TNFR1 signaling. rip ex-
pression results in the induction of cell death and NF- B
activation, and dominant negative forms of rip inhibit NF-
 B activation by TNFR1 (38, 23). Consistent with these
studies, mouse fibroblasts deficient in rip are TNF sensitive
due to an impaired antiapoptotic NF- B response (23, 24).
Figure 7. DP thymocyte survival in the absence of rip and tnfr2. To determine the contribution of TNFR2 to rip /  thymocyte apoptosis, thymus was
harvested at day 2 from rip / /tnfr2 /  mice and control littermates. Thymocytes were stained with PE–anti-CD4 and FITC–anti-CD8. Viable cells express-
ing CD4 and CD8 are shown. Six rip / /tnfr2 /  and 36 control littermates were analyzed. Two representative plots are shown for rip / /tnfr2 /  mice.
Figure 8. Nuclear NF- B in rip / /tnfr1 /  and rip / /tnfr1 /  thy-
mocytes. (A) Nuclear p65 in rip / /tnfr1 / , rip / /tnfr1 / , and rip / /
tnfr1 /  thymocytes. Thymocytes from rip / /tnfr1 /  (lanes 3 and 6),
rip / /tnfr1 /  (lanes 2 and 5), and rip / /tfnr1 /  (lanes 1 and 4) mice
were left untreated or treated with 50 ng/ml mTNF for 60 min. Wild-
type murine embryonic fibroblasts were also left untreated (lane 7) or
treated with 50 ng/ml mTNF for 60 min (lane 8). Nuclear extracts were
prepared and p65 detected by immunoblotting with anti-p65 antisera
(Santa Cruz Biotechnology, Inc.). The immunoblots were then reprobed
with an anti-mSin3A antibody to ensure that equal amounts of nuclear
protein were analyzed.24 RIP and TNFR2-induced Cell Death
To address the role of the death domain kinase rip in im-
mune regulation, we reconstituted lethally irradiated mice
with rip /  fetal liver precursors. Mice reconstituted with
rip /  precursors contained few thymocytes and mature T
cells, whereas the B lymphocyte and myeloid lineages were
unaffected. In contrast to mice reconstituted with wild-
type cells, few rip /  T cells were detected in the thymus,
spleen, or lymph node. Although TNF has been implicated
in the regulation of the CD8 lineage (11), both the CD4
and CD8 single positive T cells were affected by an absence
of rip. These studies reveal a specific T cell survival func-
tion for the TRADD kinase, rip.
The lack of rip /  T cells in the reconstituted mice does
not reflect proliferative defects as has been described for
FADD-deficient T cells (34). Surviving rip /  T cells in the
reconstituted mice were capable of responding to Con A or
anti-CD3 stimulation. Furthermore, no significant differ-
ence in the mitogenic response was observed when rip / /
tnfr1 /  and rip / /tnfr1 /  T cells were compared. Taken
together, these studies fail to demonstrate a direct role for
rip in T cell proliferation.
DP thymocytes that lack rip exhibit increased apoptosis
and fail to survive. The rip-deficient thymocytes are sensi-
tive to TNF-induced cell death, suggesting that the lack of
rip /  thymocytes and T cells is due to TNFR1-induced
cell death. Although the absence of the TNFR1 partially
rescues the RIP-associated lethality, it fails to rescue the
RIP-associated DP thymocyte apoptosis. In the absence of
RIP and TNFR1, mouse DP thymocytes fail to survive
and DN thymocytes that accumulate are arrested at the
DN3 stage (CD44  CD25 ). The increase in DN3-stage
thymocytes suggests that rip participates in thymocyte de-
velopment. Analysis of transgenic mice expressing a domi-
nant negative FADD has implicated death receptors in the
regulation of the preTCR checkpoint (39). Thus, it re-
mains possible that rip and a TNFR work in concert with
the preTCR to regulate DN3 survival and expansion.
Consistent with this notion is the fact that TNFR2 is ex-
pressed in DN3 precursors and preTCR signal has been
suggested to involve NF- B activation (39, 40). Yet, in the
absence of rip, we do not observe significant increases in
the absolute numbers of DN precursors, but instead ob-
serve on average a 22-fold decrease in the absolute num-
bers of DP thymocytes. These data are consistent with a
primary function for rip in DP thymocyte survival.
The absence of TNFR2 appears to rescue rip /  DP
thymocytes from cell death as thymocyte cell number is
normal in rip / /tnfr2 /  neonates. Thus, rip /  and rip / /
tnfr1 /  thymocytes undergo TNFR2-induced cell death,
which suggests that rip mediates TNFR2 survival signals in
thymocytes. Rip has been implicated in TNFR2 signaling
and shown to associate with TNFR2 in a TRAF2-depen-
dent manner (29). In activated T cells, RIP has been pro-
posed to recruit FADD to the TNFR2 and function as a
molecular switch, stimulating T cell death/survival. In acti-
vated T cells, TNFR2-mediated death appears to require
RIP and in contrast to TNFR1, occurs in the presence of
nuclear NF- B.
Although our data also implicates rip in TNFR2 signal-
ing, we find that in developing mouse thymocytes, rip re-
tains its antiapoptotic activity. However, the nature of the
rip-mediated TNFR2 survival signal is unclear. Thy-
mocytes from wild-type and rip / /tnfr1 /  mice exhibit
nuclear NF- B. Thus, rip / /tnfr1 /  thymocytes undergo
cell death in spite of nuclear p65, suggesting that the
TNFR2 survival signal involves mechanism(s) other than
activation of NF- B. However, it remains possible that
NF- B activation participates in TNFR2-mediated sur-
vival, as decreases in overall thymocyte cellularity have
been reported for IKK-  / /tnfr1 /  mice (35).
Thymocyte apoptosis is observed in rip /  and rip / /
tnfr1 /  thymocytes, suggesting that an absence of rip sen-
sitizes thymocytes to TNFR2-induced cell death. Sensitiv-
ity to TNFR2-induced cell death has recently been shown
to reflect cellular inhibitor of apoptosis 1 (c-IAP-1)–
induced ubiquitination and degradation of TRAF2 (41).
Here we show that the absence of rip sensitizes tnfr1 / 
thymocytes to TNFR2-induced cell death, indicating that
rip, like TRAF2, has antiapoptotic functions in TNFR2
signaling. Rip and TRAF2 interact at the TNFR1 and RIP
recruitment to TNFR2 appears TRAF2 dependent (29).
Thus, it remains possible c-IAP-1–mediated degradation of
TRAF2 may interfere with the stable recruitment of RIP
to TNFR2. Alternatively, RIP may also serve as a c-IAP-1
substrate and TNFR2-induced thymocyte cell death might
involve the degradation of both RIP and TRAF2.
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